{"id":638290,"date":"2023-02-14T19:26:01","date_gmt":"2023-02-14T19:26:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=638290"},"modified":"2023-02-14T19:26:01","modified_gmt":"2023-02-14T19:26:01","slug":"obstructive-sleep-apnea-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-apnimed-therapix-eisai-idorsia-pharma-takeda-merck","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/obstructive-sleep-apnea-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-apnimed-therapix-eisai-idorsia-pharma-takeda-merck_638290.html","title":{"rendered":"Obstructive Sleep Apnea Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies – Apnimed, Therapix, Eisai, Idorsia Pharma, Takeda, Merck"},"content":{"rendered":"
\n
\"Obstructive<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
As per DelveInsight, the Obstructive Sleep Apnea Market size in the 7MM was approximately USD 408 million in 2022 and is projected to increase during the forecast period (2022\u20132032). The market is anticipated to increase owing to rising awareness of the disease, better diagnosis, and the launch of the emerging target therapy for Obstructive Sleep Apnea.<\/div>\n

DelveInsight’s “Obstructive Sleep Apnea Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Obstructive Sleep Apnea market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).<\/p>\n

The Obstructive Sleep Apnea market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Obstructive<\/p>\n

Obstructive Sleep Apnea: An Overview<\/strong><\/p>\n

Obstructive sleep apnea (OSA) is a common, chronic, sleep-related breathing disorder characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to either complete or partial airway obstruction, resulting in apneas, hypopneas, or both. This disorder causes daytime somnolence, neurocognitive defects, and depression. Obstructive Sleep Apnea affects almost every system in the body, resulting in an increased incidence of hypertension, cardiovascular disease, stroke, pulmonary hypertension, cardiac arrhythmias, and altered immune function. It also increases the risk of an accident, presumably due to associated somnolence.<\/p>\n

According to the American Academy of Sleep Medicine, Obstructive Sleep Apnea is a sleep-related breathing disorder that involves a decrease or complete halt in airflow despite an ongoing effort to breathe. It occurs when the muscles relax during sleep, causing soft tissue in the back of the throat to collapse and block the upper airway.<\/em><\/p>\n

Obstructive Sleep Apnea Market Key Facts<\/strong><\/p>\n